Category Archives: MS Treatment

BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders, today announced the appointment of Laurie Olson to its Board of Directors effective August 12, 2020. Continue reading →

The Progressive Relapsing Multiple Sclerosis Treatment market report offers an all-inclusive analysis of this industry vertical with emphasis on the key growth drivers, limitations, and opportunities shaping the market dynamics in the upcoming years. As per the report, the market is projected to show decent growth, recording a CAGR of XX% over the analysis period (2020-2025). Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/33675 Fluctuations in supply and demand share due to enforcement of stringent lockdown measures to address the COVID-19 pandemic have left several businesses in disarray Continue reading →

During a virtual Case Based Peer Perspective event, Jonathon B. Cohen, MD, MS, the codirector of the Lymphoma Program, medical director of Infusion Servies, and associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine and Winship Cancer Institute, discussed a case of a 71-year-old woman diagnosed with chronic lymphocytic leukemia. Targeted Oncology: What are reasonable treatment options to consider in a patient with CLL Continue reading →

ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure (NASDAQ:NVCR) today announced an expansion of its Executive Leadership Team, effective Sept. 1, 2020, intended to further solidify executive leadership in preparation for an anticipated period of significant innovation and growth and to recognize the proven senior management experience of key Novocure leaders Continue reading →

Q2 2020 Helius Medical Technologies Inc Earnings Call Aug 13, 2020 (Thomson StreetEvents) -- Edited Transcript of Helius Medical Technologies Inc earnings conference call or presentation Wednesday, August 12, 2020 at 9:00:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Joyce N. LaViscount Helius Medical Technologies, Inc. - CFO, COO & Secretary * Philippe Deschamps Helius Medical Technologies, Inc. Continue reading →

The family of a woman, left brain dead after paramedics treated her for a severe asthma attack, has lost a High Court battle against the Queensland Government in a $3 million negligence case. Jennifer Leanne Masson, 25, arrived at a friend's house in Brinsmead, Cairns, on the night of July 21, 2002, when she had an asthma attack and collapsed on the front lawn. Two ambulance crews arrived six minutes later with intensive care paramedic Clinton Peters, who administered Ms Masson with an intravenous salbutamol in an attempt to open up her airways before she was transferred to Cairns Base Hospital Continue reading →

INTRODUCTION Combination antiretroviral therapy (cART) causes a drastic and immediate viral decrease by targeting distinct steps in the HIV-1 life cycle, effectively blocking replication and halting disease progression (13). However, cART does not target or eliminate HIV that persists in a latent state in cellular reservoirs. Continue reading →

August 13, 2020 07:00 ET | Source: TG Therapeutics, Inc. NEW YORK, Aug Continue reading →

LAKE FOREST, Calif., Aug. Continue reading →

Multiple sclerosis is characterized by damage to myelin, which alters the communication between nerve cells and leads to multiple symptoms. Multiple Sclerosis Although there is no cure for multiple sclerosis, several research teams are working on reducing its symptoms. A phase III clinical trial seems to conclude that Ofatumumab is a promising drug. Continue reading →